Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

被引：0
|
作者：
Vader, Maartje J. C. [1 ]
Schauwvlieghe, Ann-Sofie M. E. [1 ]
Verbraak, Frank D. [1 ]
Dijkman, Greetje [2 ]
Hooymans, Johanna M. M. [3 ]
Los, Leonie I. [3 ]
Zwinderman, Aeilko H. [4 ]
Peto, Tunde [5 ]
Hoyng, Carel B. [6 ]
van Leeuwen, Redmer [7 ]
Vingerling, Johannes R. [8 ]
Moll, Annette C. [1 ]
van Lith-Verhoeven, Janneke J. C. [9 ]
Dijkgraaf, Marcel G. W. [10 ]
Schlingemann, Reinier O. [1 ,11 ]
机构：
[1] Univ Amsterdam, Amsterdam UMC, Ophthalmol, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Ophthalmol, Leiden, Netherlands
[3] Univ Med Ctr Groningen, Ophthalmol, Groningen, Netherlands
[4] Univ Amsterdam, Amsterdam UMC, Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands
[5] Queens Univ Belfast, Ophthalmol, Belfast, Antrim, North Ireland
[6] Radboud Univ Nijmegen, Ophthalmol, Med Ctr, Nijmegen, Netherlands
[7] Univ Med Ctr Utrecht, Ophthalmol, Utrecht, Netherlands
[8] Erasmus MC, Ophthalmol, Rotterdam, Netherlands
[9] Elisabeth Twee Steden ETZ Hosp, Ophthalmol, Tilburg, Netherlands
[10] Univ Amsterdam, Amsterdam UMC, Clin Res Unit, Amsterdam, Netherlands
[11] Univ Lausanne, Ophthalmol, Jules Gonin Eye Hosp, Lausanne, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3648
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME) The BRDME Study, a Randomized Trial
    Vader, Maartje J. C.
    Schauwvlieghe, Ann-Sofie M. E.
    Verbraak, Frank D.
    Dijkman, Greetje
    Hooymans, Johanna M. M.
    Los, Leonoor, I
    Zwinderman, Aeilko H.
    Peto, Tunde
    Hoyng, Carel B.
    van Leeuwen, Redmer
    Vingerling, Johannes R.
    Moll, Annette C.
    Van Lith-Verhoeven, Janneke J. C.
    Dijkgraaf, Marcel G. W.
    Schlingemann, Reinier O.
    OPHTHALMOLOGY RETINA, 2020, 4 (08): : 777 - 788
  • [2] Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema. The BRDME study
    Vader, M. J. C.
    Schauwvlieghe, A. M. E.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Zwinderman, A. H.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Dijkgraaf, M. G. W.
    Schlingemann, R. O.
    ACTA OPHTHALMOLOGICA, 2019, 97 : 40 - 40
  • [3] COMPARING THE EFFICACY OF BEVACIZUMAB TO RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR OEDEMA: THE BRDME STUDY
    Schlingemann, R. O.
    Vader, M. J. C.
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Zwinderman, A. H.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Dijkgraaf, M. G. W.
    Verbraak, F. D.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP18 - NP19
  • [4] Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M.
    Verbraak, F. D.
    Hoyng, C. B.
    Dijkgraaf, M. G. W.
    Van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    Schlingemann, Reinier O.
    BMC OPHTHALMOLOGY, 2015, 15
  • [5] Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)
    A.M.E. Schauwvlieghe
    G. Dijkman
    J.M. Hooymans
    F.D. Verbraak
    C.B. Hoyng
    M.G.W. Dijkgraaf
    R. Van Leeuwen
    J.R. Vingerling
    A.C. Moll
    Reinier O. Schlingemann
    BMC Ophthalmology, 15
  • [6] PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY
    Fickweiler, Ward
    Schauwvlieghe, Ann-Sofie M. E.
    Schlingemann, Reinier O.
    Hooymans, Johanna M. Maria
    Los, Leonoor, I
    Verbraak, Frank D.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (04): : 812 - 819
  • [7] Cost-effectiveness of bevacizumab versus ranibizumab in patients with diabetic macular edema. Analysis from the BRDME study
    Vader, M. J. C.
    Verbraak, F. D.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Schlingemann, R. O.
    Dijkgraaf, M. G. W.
    ACTA OPHTHALMOLOGICA, 2020, 98 : 42 - 42
  • [8] Efficacy of Ranibizumab in the Treatment of Diabetic Macular Edema Refractory to Bevacizumab
    Sciulli, Harrison
    Miller, David
    Coney, Joseph
    Novak, Michael
    Schartman, Jerome
    Singerman, Lawrence
    Zegarra, Hernando
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [9] Ranibizumab for the treatment of diabetic macular edema in patients treated with Bevacizumab
    Velez, Gisela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [10] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
12345